Patent · US Expired

Anti-sickling hemoglobin

US5864029A · kind A · utility

5Cited by
0References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 5, 1995
Grant dateJan 26, 1999
Priority date
Expiry dateJun 5, 2015

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are anti-sickling human hemoglobins for use as sickle cell anemia therapeutics.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.